Cargando…
Paradoxical Bronchoconstriction with Short-Acting Beta Agonist
Patient: Male, 25 Final Diagnosis: Paradoxical bronchospasm Symptoms: Dyspnea on exertion • shortness of breath Medication: Albuterol • levalbuterol Clinical Procedure: Pulmonary function testing Specialty: General and Internal Medicine OBJECTIVE: Unusual clinical course BACKGROUND: Asthma is a comm...
Autores principales: | Magee, Jared S., Pittman, Luke M., Jette-Kelly, Leslie A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192384/ https://www.ncbi.nlm.nih.gov/pubmed/30297688 http://dx.doi.org/10.12659/AJCR.910888 |
Ejemplares similares
-
Paradoxical bronchoconstriction caused by β(2)-adrenoceptor agonists
por: Ayed, Khadija, et al.
Publicado: (2020) -
Sensitivity of Lung Resistance and Compliance to Beta-Blocker Induced Bronchoconstriction and Long Acting Beta-Agonist Withdrawal in COPD
por: Jabbal, Sunny, et al.
Publicado: (2017) -
Lack of paradoxical bronchoconstriction after administration of tiotropium via Respimat(®) Soft Mist™ Inhaler in COPD
por: Hodder, Rick, et al.
Publicado: (2011) -
Overuse of Short-Acting Beta-2 Agonists (SABAs) in Elite Athletes: Hypotheses to Explain It
por: Vertadier, Nicolas, et al.
Publicado: (2022) -
Over-the-counter use of short-acting beta-2 agonists: a systematic review
por: Loh, Zhe Chi, et al.
Publicado: (2023)